Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes
Not every patient will benefit, and those who do will benefit in different ways depending on their diagnoses, BMI, and which program they qualify for
But, studies with mice suggest that ipamorelins half-life is longer than sermorelinit lasts around 2 to 3 hours
Image Credit: Pietukhova / Shutterstock In a recent perspective in the journal Obesity , researchers discussed recent medical developments that have not only revolutionized the treatment of diabetes and obesity, but whose popularity has also quickly spread among groups who lack clinical indication for obesity or diabetes treatment
doi:10.1111/jdi.12450 59
For example, CureGardens Beauty Collagen Drink contains 4000 mg of marine collagen plus 250 mg of L-glutathione per serving